✦ LIBER ✦

Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial

✍ Scribed by B. Walter, I. Schrettenbrunner, M. Vogelhuber, J. Grassinger, K. Bross, J. Wilke, T. Suedhoff, A. Berand, W. F. Wieland, S. Rogenhofer, R. Andreesen, A. Reichle

Book ID: 113093745
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 234 KB
Volume: 29
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-011-9982-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of capecitabine and rHu-i

Phase II trial of capecitabine and rHu-interferon-α-2a in patients with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity

✍ Ena Segota; Tarek Mekhail; Thomas Olencki; Thomas E. Hutson; Robert Dreicer; Bre 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Sequential administration of interferon

Sequential administration of interferon γ and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial

✍ Manuela Schmidinger; Günther G. Steger; Catharina Wenzel; Gottfried J. Locker; T 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 111 KB

Phase 3 trial of everolimus for metastat

Phase 3 trial of everolimus for metastatic renal cell carcinoma : Final results and analysis of prognostic factors

✍ Robert J. Motzer; Bernard Escudier; Stephane Oudard; Thomas E. Hutson; Camillo P 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB 👁 2 views

A phase I clinical trial of low-dose int

A phase I clinical trial of low-dose interferon-α-2A, thalidomide plus gemcitabine and capecitabine for patients with progressive metastatic renal cell carcinoma

✍ Robert J. Amato; Muhammad Khan 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 221 KB

Phase II trial of 5-fluorouracil, interf

Phase II trial of 5-fluorouracil, interferon-α and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma

✍ Julie A. Ellerhorst; Avishay Sella; Robert J. Amato; Shi-Ming Tu; Randall E. Mil 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## RESULTS. Fifty-five patients were enrolled in the trial and 52 were evaluable for ogy, The University of Texas M. D. Anderson response. All patients experienced fever and flu-like symptoms. Grade 3 or 4 nonhe-Cancer Center, Houston, Texas. matologic toxic effects included hypertension (48%), d

SORAFENIB PLUS INTERFERON-α2A IN METASTA

SORAFENIB PLUS INTERFERON-α2A IN METASTATIC RENAL CELL CARCINOMA: RESULTS FROM RAPSODY (GOIRC STUDY 0681), A RANDOMISED PROSPECTIVE PHASE II TRIAL OF TWO DIFFERENT TREATMENT SCHEDULES

✍ S. Bracarda; C. Porta; C. Boni; A. Santoro; F. Artioli; A. Contu; L. Mentuccia; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 74 KB